Cargando…

Cell-free mitochondrial DNA in progressive multiple sclerosis

Recent studies have linked cell-free mitochondrial DNA (ccf-mtDNA) to neurodegeneration in both Alzheimer's and Parkinson's disease, raising the possibility that the same phenomenon could be seen in other diseases which manifest a neurodegenerative component. Here, we assessed the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lowes, Hannah, Pyle, Angela, Duddy, Martin, Hudson, Gavin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509276/ https://www.ncbi.nlm.nih.gov/pubmed/30098422 http://dx.doi.org/10.1016/j.mito.2018.07.008

Ejemplares similares

Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
por: Lowes, Hannah, et al.
Publicado: (2020)

Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease
por: Lowes, Hannah, et al.
Publicado: (2020)

Mitochondrial DNA Damage and Brain Aging in Human Immunodeficiency Virus
por: Roca-Bayerri, Carla, et al.
Publicado: (2020)

Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease
por: Pyle, Angela, et al.
Publicado: (2016)

No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis
por: Campbell, Graham R, et al.
Publicado: (2013)

Extreme-Depth Re-sequencing of Mitochondrial DNA Finds No Evidence of Paternal Transmission in Humans
por: Pyle, Angela, et al.
Publicado: (2015)

Frailty and mortality are not influenced by mitochondrial DNA haplotypes in the very old()
por: Collerton, Joanna, et al.
Publicado: (2013)

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
por: Campbell, Graham R, et al.
Publicado: (2011)

Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis
por: Blagov, Alexander V., et al.
Publicado: (2022)

Transition to secondary progressive multiple sclerosis: The consequences for patients and healthcare systems, a healthcare professional survey
por: Caseby, Sophie Clare Laura, et al.
Publicado: (2022)

The impact of smoking cessation on multiple sclerosis disease progression
por: Rodgers, Jeff, et al.
Publicado: (2021)

Investigation of the Role of Mitochondrial DNA in Multiple Sclerosis Susceptibility
por: Ban, Maria, et al.
Publicado: (2008)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

Silent progression in disease activity–free relapsing multiple sclerosis
por: Cree, Bruce A. C., et al.
Publicado: (2019)

Somatic mtDNA variation is an important component of Parkinson's disease
por: Coxhead, Jonathan, et al.
Publicado: (2016)

Heteroplasmic mitochondrial DNA variants in cardiovascular diseases
por: Calabrese, Claudia, et al.
Publicado: (2022)

Mitochondrial DNA haplogroup analysis in Saudi Arab patients with multiple sclerosis
por: Al-Kafaji, Ghada, et al.
Publicado: (2022)

Deciphering Multiple Sclerosis Progression
por: Meca-Lallana, Virginia, et al.
Publicado: (2021)

Mitochondrial Dysfunction and Multiple Sclerosis
por: de Barcelos, Isabella Peixoto, et al.
Publicado: (2019)

Feasibility and impact of haplogroup matching for mitochondrial replacement treatment
por: Takeda, Yuko, et al.
Publicado: (2023)

Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis
por: Lewin, Alex, et al.
Publicado: (2016)

Accurate mitochondrial DNA sequencing using off-target reads provides a single test to identify pathogenic point mutations
por: Griffin, Helen R., et al.
Publicado: (2014)

An observational study of alemtuzumab following fingolimod for multiple sclerosis
por: Willis, Mark, et al.
Publicado: (2017)

LINE-1 Hypermethylation in Serum Cell-Free DNA of Relapsing Remitting Multiple Sclerosis Patients
por: Dunaeva, Marina, et al.
Publicado: (2017)

Progression in multiple sclerosis is associated with low endogenous NCAM
por: Gnanapavan, Sharmilee, et al.
Publicado: (2013)

Extracellular Vesicles in Amyotrophic Lateral Sclerosis
por: McCluskey, Gavin, et al.
Publicado: (2022)

Is multiple sclerosis a mitochondrial disease?
por: Mao, Peizhong, et al.
Publicado: (2010)

Mitochondrial DNA sequence characteristics modulate the size of the genetic bottleneck
por: Wilson, Ian J., et al.
Publicado: (2016)

Progress in Multiple Sclerosis Genetics
por: Goris, An, et al.
Publicado: (2012)

Mitochondrial DNA and traumatic brain injury
por: Bulstrode, Harry, et al.
Publicado: (2014)

A genome-wide association study of mitochondrial DNA copy number in two population-based cohorts
por: Guyatt, Anna L., et al.
Publicado: (2019)

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
por: Su, Kimmy, et al.
Publicado: (2013)

Secondary Progressive Multiple Sclerosis: New Insights
por: Cree, Bruce A.C., et al.
Publicado: (2021)

Stem Cell Therapies for Progressive Multiple Sclerosis
por: Smith, Jayden A., et al.
Publicado: (2021)

Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2018)

Chronic lesion activity and disability progression in secondary progressive multiple sclerosis
por: Beynon, Vanessa, et al.
Publicado: (2022)

Mitochondrial defects in acute multiple sclerosis lesions
por: Mahad, Don, et al.
Publicado: (2008)

Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder
por: Lindqvist, Daniel, et al.
Publicado: (2018)

UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
por: Palace, Jacqueline, et al.
Publicado: (2014)

Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care
por: Martin, Jessica E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_coqql00e88sigveij3a9u2nna9